諾華公司 - 存託憑證（普通股）
DE ˙ DB ˙ US66987V1098
€121.00 0.00 (0.00%)
2026-06-04
分享價格
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionEthic Inc.
Latest Disclosed Ownership103,551 shares
Latest Disclosed Value $ 15,817,357
Ethic Inc. reports 10.32% increase in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On April 27, 2026 - Ethic Inc. filed a 13F-HR form disclosing ownership of 103,551 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $13,306,304 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 93,865 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 10.32% during the quarter. The current value of the position is $12,529,671 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F NOVARTIS AG SP ADR SPONSORED ADR 66987V109 103,551 9,686 10.32 15,817 22.22 0.2477
2026-02-03 2025-12-31 13F NOVARTIS AG SP ADR SPONSORED ADR 66987V109 93,865 3,010 3.31 12,941 11.07 0.1990
2025-10-17 2025-09-30 13F NOVARTIS AG SP ADR ADR 66987V109 90,855 9,507 11.69 11,651 19.35 0.1917
2025-07-30 2025-06-30 13F NOVARTIS AG SP ADR ADR 66987V109 81,348 -4,573 -5.32 9,763 3.66 0.1749
2025-05-13 2025-03-31 13F NOVARTIS AG SP ADR ADR 66987V109 85,921 -33,752 -28.20 9,418 -19.13 0.1908
2025-02-14 2024-12-31 13F NOVARTIS AG SP ADR ADR 66987V109 119,673 -13,074 -9.85 11,645 -9.31 0.2350
2024-11-13 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 132,747 -8,210 -5.82 12,841 -14.43 0.3245
2024-08-13 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 140,957 8,210 6.18 15,006 16.87 0.3519
2024-05-13 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 132,747 7,987 6.40 12,841 1.94 0.3244
2024-02-14 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 124,760 11,780 10.43 12,597 9.45 0.3726
2023-11-14 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 112,980 13,489 13.56 11,508 14.63 0.4038
2023-08-14 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 99,491 -1,612 -1.59 10,040 7.93 0.3722
2023-05-12 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 101,103 -2,691 -2.59 9,301 -1.22 0.3774
2023-02-14 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 103,794 33,521 47.70 9,416 76.30 0.5087
2022-11-14 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 70,273 -11,612 -14.18 5,341 -22.84 0.3625
2022-08-10 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 81,885 4,598 5.95 6,922 2.06 0.4825
2022-05-16 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 77,287 37,008 91.88 6,782 92.51 0.4681
2022-02-14 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 40,279 3,564 9.71 3,523 17.32 0.2716
2021-11-15 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 36,715 12,850 53.84 3,003 37.94 0.3074
2021-08-10 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 23,865 12,675 113.27 2,177 127.48 0.2639
2021-05-13 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 11,190 2,162 23.95 957 12.19 0.1706
2021-02-10 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 9,028 3,890 75.71 853 90.83 0.2255
2020-10-27 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 5,138 -221 -4.12 447 -4.49 0.1709
2020-08-12 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 5,359 2,565 91.80 468 103.48 0.2663
2020-05-15 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,794 2,794 230 0.1920
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.